BVS Bioventus Inc. logo

BVS Bioventus Inc.

Healthcare
$9.28-2.26%ClosedMarket Cap: $628.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

26.85

PEG

0.16

P/B

3.31

P/S

1.09

EV/EBITDA

5.68

DCF Value

$-2.37

FCF Yield

16.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

67.8%

Operating Margin

10.6%

Net Margin

4.9%

ROE

16.3%

ROA

4.4%

ROIC

11.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$132.1M$3.1M$
Q4 null$157.9M$14.8M$
FY null$568.1M$22.7M$
Q3 null$138.7M$3.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$13.00

Target (Median)

$13.00

Target Range

$13.00 - $13.00

2 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Barrington ResearchOutperform
2026-05-22
Craig-HallumBuy
2026-03-06
Barrington ResearchOutperform
2026-03-06

Trading Activity

Insider Trades

View All
Singleton Mark Leonardofficer: SVP & CFO
SellTue Apr 14
Singleton Mark Leonardofficer: SVP & CFO
SellTue Apr 14
D'Adamio Anthonyofficer: SVP & General Counsel
SellTue Apr 14
D'Adamio Anthonyofficer: SVP & General Counsel
SellTue Apr 14
Cowdy Philip G.director
SellTue Apr 14

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.72

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Peers